Canada Markets close in 13 mins

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
78.900.00 (0.00%)
As of 03:12PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close78.90
Open78.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range78.90 - 78.90
52 Week Range78.78 - 97.30
Volume30
Avg. Volume25,116
Market Cap177.871B
Beta (5Y Monthly)0.52
PE Ratio (TTM)22.67
EPS (TTM)3.48
Earnings DateN/A
Forward Dividend & Yield3.22 (3.47%)
Ex-Dividend DateMar. 04, 2021
1y Target EstN/A
  • Zacks

    Novartis (NVS) Highlights Growth Profile at its R&D Day

    Novartis (NVS) throws light on its pipeline progress, key areas of focus and long-term targets at its R&D day. Here, we discuss key highlights from the same.

  • Zacks

    Aurinia (AUPH) Stock Up on Potential Acquisition Rumors

    Aurinia (AUPH) gains on rumors of a potential acquisition yet again. Reportedly, the company is being eyed by Novartis.

  • Motley Fool

    Why Aurinia Pharmaceuticals Stock Bolted Higher Today

    Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. ET Thursday afternoon. Rumors began to swirl about a possible buyout this morning after Novartis (NYSE: NVS) reportedly said during its research and development day that it will focus on smaller bolt-on acquisitions, instead of megadeals. Aurinia has repeatedly been the topic of the buyout rumor mill in 2021.